HIV Funding Impacts Global health funding · LMIC Download the panel

Home  /  Western and Central Africa  /  MRT

Mauritania

Mauritania appears only through international and donor bodies that compile figures across many countries, and no figures for the country are read directly from a national publisher. The assessment of national sources, country by country, is set out on the Methods page.

5,800
People living with HIV, 2025
WHO Global Health Observatory
81.0%
On antiretroviral treatment, 2025
WHO Global Health Observatory
$154k
United States HIV disbursements, 2024
ForeignAssistance.gov
$1.1m
External HIV financing, all donors, 2024
OECD Creditor Reporting System
External HIV financing
OECD CRS · ForeignAssistance.gov
$0$2m$4m$6m20022005200820112014201720202023$1.1m$395k$11k$154k
  • All donors
  • United States, OECD record
  • The Global Fund
  • United States, self-reported
YearAll donorsUnited States, OECD recordThe Global FundUnited States, self-reported
2002 $55k — — —
2003 $108k — — —
2004 $943k — — —
2005 $906k — — —
2006 $2.9m $40k $1.6m $40k
2007 $1.8m $39k — $39k
2008 $6.1m $8k $4.5m $8k
2009 $781k $1k $382k $1k
2010 $202k $47k — $47k
2011 $727k — — $5k
2012 $2.6m — $1.9m —
2013 $3.2m $72k $2.7m $72k
2014 $1.3m — $945k —
2015 $1.6m — $1.3m —
2016 $2.1m — $2.0m —
2017 $505k — $321k —
2018 $828k — $751k —
2019 $985k — $829k —
2020 $1.1m — $11k —
2021 $97k — — —
2022 $26k — — —
2023 $1.5m $395k — $246k
2024 $1.1m — — $154k

23 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Disbursements reported for the country. The OECD record and the United States self-reported record are drawn separately. The two records cover the same United States disbursements, but the OECD record is filed by calendar year and the self-reported record by United States fiscal year.

People living with HIV and people on treatment
UNAIDS AIDSinfo
05k10k2000200320062009201220152018202120245,9004,500
  • People living with HIV
  • People on treatment
YearPeople living with HIVPeople living with HIV (lower)People living with HIV (upper)People on treatment
2000 9,700 8,000 12,000 —
2001 10,000 8,400 12,000 —
2002 11,000 8,900 12,000 —
2003 11,000 9,100 13,000 —
2004 11,000 9,300 13,000 —
2005 11,000 9,400 12,000 —
2006 11,000 9,400 12,000 —
2007 11,000 9,200 12,000 —
2008 10,000 9,100 12,000 —
2009 10,000 8,800 12,000 —
2010 9,600 8,400 11,000 1,600
2011 9,200 8,000 11,000 1,700
2012 8,800 7,600 10,000 1,800
2013 8,400 7,200 9,900 2,100
2014 7,900 6,800 9,500 2,300
2015 7,500 6,400 9,000 2,500
2016 7,200 6,200 8,600 2,600
2017 6,900 5,900 8,300 3,000
2018 6,700 5,700 8,000 3,000
2019 6,400 5,600 7,800 3,300
2020 6,300 5,400 7,500 3,400
2021 6,100 5,300 7,300 3,600
2022 6,100 5,200 7,200 3,800
2023 6,000 5,100 7,200 4,200
2024 5,900 5,100 7,100 4,500

25 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Modelled estimates. The shaded area is the published uncertainty interval around the number of people living with HIV, because a single estimate without the interval would overstate the precision of the model.

The treatment cascade
UNAIDS AIDSinfo
0%20%40%60%80%2010201220142016201820202022202478.0%76.0%
  • Diagnosed
  • On treatment
YearDiagnosedOn treatment
2010 20.0% 17.0%
2011 22.0% 19.0%
2012 25.0% 21.0%
2013 30.0% 26.0%
2014 33.0% 28.0%
2015 37.0% 33.0%
2016 41.0% 36.0%
2017 46.0% 44.0%
2018 50.0% 45.0%
2019 54.0% 51.0%
2020 58.0% 54.0%
2021 62.0% 59.0%
2022 65.0% 62.0%
2023 72.0% 70.0%
2024 78.0% 76.0%

15 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Every line is a percentage of all people living with HIV, so the three lines share a denominator and can be compared directly. Viral suppression in the figure is the share of all people living with HIV who are virally suppressed, and not the narrower third 95 target, which counts only people on treatment.

Sources of the figures for Mauritania

2,826 rows

SourceTypeRowsIndicators YearsRead fromRetrieved
UNICEF HIV/AIDS dataset Modelled estimate 1,376 5 2010–2025 sdmx.data.unicef.org 2026-10-20
UNAIDS AIDSinfo Modelled estimate 749 25 2000–2024 aidsinfo.unaids.org 2026-10-20
WHO Global Health Observatory Modelled estimate 227 10 2000–2025 ghoapi.azureedge.net 2026-10-12
WHO Global Tuberculosis Programme Programme record 98 16 2000–2024 extranet.who.int 2026-10-16
WHO Global Health Expenditure Database Expenditure account 63 7 2013–2021 apps.who.int 2026-10-12
Demographic and Health Surveys Survey 62 2 2020 api.dhsprogram.com 2026-10-16
Global Fund Data Service Programme record 62 8 2017–2025 fetch.theglobalfund.org 2026-10-12
IATI, through d-portal Expenditure account 52 3 2000–2026 d-portal.org 2026-10-12
World Bank Open Data Modelled estimate 51 2 2000–2025 api.worldbank.org 2026-10-12
OECD Creditor Reporting System Expenditure account 42 3 2002–2024 sdmx.oecd.org 2026-10-12
ForeignAssistance.gov Expenditure account 18 3 2006–2024 foreignassistance.gov 2026-10-29
WHO HIV testing services dashboard Programme record 14 4 2018–2023 eic-database-290813.ew.r.appspot.com 2026-10-14
UNAIDS Global AIDS Monitoring expenditure database Expenditure account 5 5 2018 hivfinancial.unaids.org 2026-10-12
Global Fund allocations Expenditure account 4 1 2017–2026 fetch.theglobalfund.org 2026-10-12
UNAIDS Data 2025 country databook Expenditure account 3 3 2018 aidsinfo.unaids.org 2026-10-15

Indicators held

66 of 150

IndicatorDomainUnitRows YearsSourcesMost recent value
Actual expenditure on collaborative TB/HIV activities Financing USD 1 2018 WHO Global Tuberculosis Programme $0 (2018)
Budget required for collaborative TB/HIV activities Financing USD 1 2019 WHO Global Tuberculosis Programme $55k (2019)
Country-reported HIV expenditure, all sources Financing USD 2 2012–2013 UNAIDS AIDSinfo $2.7m (2013)
Domestic funding received by the national TB programme Financing USD 2 2018–2020 WHO Global Tuberculosis Programme $187k (2020)
Domestic public HIV expenditure Financing USD 2 2018 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $1.2m (2018)
Expected Global Fund funding for the national TB programme Financing USD 5 2018–2023 WHO Global Tuberculosis Programme $1.8m (2023)
Expected USAID funding for the national TB programme Financing USD 3 2018–2023 WHO Global Tuberculosis Programme $0 (2023)
Expected domestic funding for the national TB programme Financing USD 3 2019–2023 WHO Global Tuberculosis Programme $10k (2023)
Expected funding for collaborative TB/HIV activities Financing USD 2 2019–2023 WHO Global Tuberculosis Programme $213k (2023)
External HIV and STD spending, national health accounts Financing USD 9 2013–2021 WHO Global Health Expenditure Database $2.5m (2021)
External HIV financing (all donors, ODA) Financing USD 23 2002–2024 OECD Creditor Reporting System $1.1m (2024)
External HIV financing from governments other than the United States (IATI) Financing USD 18 2000–2025 IATI, through d-portal $37k (2025)
External HIV financing from multilateral bodies other than the Global Fund (IATI) Financing USD 15 2012–2026 IATI, through d-portal $41k (2026)
External HIV financing from the United States (ODA) Financing USD 16 2006–2024 ForeignAssistance.gov, OECD Creditor Reporting System $154k (2024)
Funding received for collaborative TB/HIV activities Financing USD 1 2018 WHO Global Tuberculosis Programme $0 (2018)
Global Fund HIV allocation for a whole three-year cycle, not an annual figure Financing USD per three-year allocation cycle 4 2017–2026 Global Fund allocations 4,308,421 (2026)
Global Fund HIV disbursements to the country Financing USD 32 2006–2026 IATI, through d-portal, OECD Creditor Reporting System, UNAIDS Global AIDS Monitoring expenditure database $114k (2026)
Global Fund funding received by the national TB programme Financing USD 4 2017–2020 WHO Global Tuberculosis Programme $984k (2020)
Government HIV and STD spending as a share of government health spending Financing percent 9 2013–2021 WHO Global Health Expenditure Database 1.0% (2021)
Government HIV and STD spending, national health accounts Financing USD 9 2013–2021 WHO Global Health Expenditure Database $1.3m (2021)
HIV and STD spending as a share of all external health spending Financing percent 9 2013–2021 WHO Global Health Expenditure Database 7.6% (2021)
HIV and STD spending as a share of all health spending Financing percent 9 2013–2021 WHO Global Health Expenditure Database 6.4% (2021)
HIV and STD spending, national health accounts Financing USD 9 2013–2021 WHO Global Health Expenditure Database $22.5m (2021)
International HIV expenditure (country-reported) Financing USD 2 2018 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $2.2m (2018)
Out-of-pocket HIV expenditure by households Financing USD 1 2018 UNAIDS Global AIDS Monitoring expenditure database $186k (2018)
Private HIV and STD spending, national health accounts Financing USD 9 2013–2021 WHO Global Health Expenditure Database $18.7m (2021)
Private HIV expenditure (country-reported) Financing USD 2 2018 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $186k (2018)
US HIV disbursements managed by USAID Financing USD 2 2023–2024 ForeignAssistance.gov $154k (2024)
US HIV disbursements managed by other US agencies Financing USD 7 2006–2013 ForeignAssistance.gov $72k (2013)
USAID funding received by the national TB programme Financing USD 2 2017–2018 WHO Global Tuberculosis Programme $0 (2018)
% of PLHIV on ART (second 95, PLHIV base) Treatment cascade percent 67 2000–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 81.0% (2025)
% of PLHIV who have been diagnosed (first 95) Treatment cascade percent 26 2010–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 83.0% (2025)
% of estimated HIV-positive incident TB cases on TB treatment and ART Treatment cascade percent 13 2005–2023 UNAIDS AIDSinfo 36.2% (2023)
% of people newly enrolled in HIV treatment diagnosed with TB disease Treatment cascade percent 5 2013–2018 UNAIDS AIDSinfo 4.6% (2018)
% of people newly enrolled in HIV treatment started on TB preventive therapy Treatment cascade percent 3 2013–2016 UNAIDS AIDSinfo 0.1% (2016)
% of returned HIV test results that were positive Treatment cascade percent 7 2018–2023 UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard 0.4% (2023)
HIV tests performed at a health facility Treatment cascade count 3 2018–2023 WHO HIV testing services dashboard 79,825 (2023)
HIV tests performed through community outreach Treatment cascade count 3 2018–2023 WHO HIV testing services dashboard 1,237 (2023)
HIV tests performed with the result returned to the person Treatment cascade count 12 2018–2024 Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard 1,683 (2024)
HIV-exposed infants tested within two months of birth Treatment cascade percent 1 2016 UNAIDS AIDSinfo 10.0% (2016)
HIV-positive TB patients started or continued on ART Treatment cascade count 13 2018–2025 Global Fund Data Service, WHO Global Tuberculosis Programme 62 (2025)
Key-population people tested for HIV (count over the period) Treatment cascade count 12 2018–2025 Global Fund Data Service By population group, sex or age only, to 2025
New HIV diagnoses with a CD4 count below 200 Treatment cascade percent 2 2015–2016 UNAIDS AIDSinfo 46.0% (2016)
Number of people on ART (PEPFAR MER TX_CURR) Treatment cascade count 76 2000–2025 Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory 4,681 (2025)
PMTCT ART coverage among pregnant women with HIV Treatment cascade percent 31 2010–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset 95.0% (2025)
People living with HIV on ART who started TB preventive therapy Treatment cascade count 1 2025 Global Fund Data Service 1,109 (2025)
People newly enrolled on ART during the year Treatment cascade count 5 2013–2018 WHO Global Tuberculosis Programme 435 (2018)
People tested for HIV in the last 12 months who received the result (household survey) Treatment cascade percent 30 2020 Demographic and Health Surveys By population group, sex or age only, to 2020
Pregnant women tested for HIV in antenatal care Treatment cascade percent 6 2015–2024 UNAIDS AIDSinfo 60.0% (2024)
Pregnant women with HIV who received ARVs for PMTCT Treatment cascade count 40 2010–2025 Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory 162 (2025)
TB patients recorded as HIV-positive Treatment cascade count 6 2018–2023 WHO Global Tuberculosis Programme 49 (2023)
TB patients with an HIV test result recorded Treatment cascade count 14 2016–2025 Global Fund Data Service, WHO Global Tuberculosis Programme 2,257 (2025)
AIDS-related deaths Epidemic estimates count 681 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 200 (2025)
Deaths from TB among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 25 (2024)
HIV prevalence among a key population Epidemic estimates percent 3 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
HIV prevalence, ages 15-49 Epidemic estimates percent 50 2000–2024 UNAIDS AIDSinfo, World Bank Open Data 0.1% (2024)
Incident TB cases among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 85 (2024)
New HIV infections Epidemic estimates count 585 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 200 (2025)
People living with HIV Epidemic estimates count 681 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 5,800 (2025)
Key-population people reached by outreach (count over the period) Prevention and outreach count 12 2018–2025 Global Fund Data Service By population group, sex or age only, to 2025
Male condoms distributed in a year Prevention and outreach count 2 2019–2020 UNAIDS AIDSinfo 1,500,000 (2020)
People with comprehensive correct knowledge of HIV (household survey) Prevention and outreach percent 32 2020 Demographic and Health Surveys By population group, sex or age only, to 2020
Estimated pregnant women with HIV needing ARVs for PMTCT Population denominators count 31 2010–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 200 (2025)
Estimated size of a key population Population denominators count 3 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
Total population Population denominators count 26 2000–2025 World Bank Open Data 5,315,065 (2025)
Share of HIV-exposed infants who acquire HIV — percent 31 2010–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset 10.8% (2025)

Every row shown on the Mauritania page is in the panel download, with the source URL and the retrieval date of the row attached. See Data.